The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation
FDA Law
SEPTEMBER 29, 2021
Manufacturers may choose not to participate in this program, but the federal government will not reimburse for their outpatient drugs under Medicaid or Medicare Part B if they do not. A 2018 report by the Government Accountability Office (“GAO”) found similar issues, as well as contract pharmacy noncompliance and poor federal oversight.
52 
Let's personalize your content